Want to join the conversation?
$AFL 2Q15 PR: For 3Q15, if yen averages 120 to 125, diluted EPS is expected to be approx. $1.40-1.53. On same exchange rate assumption, full-year operating diluted EPS expected to be $5.88-6.17. Amos, CEO stated that Company faces difficult sales comparison in 4Q and anticipates sales of cancer and medical products to increase 7-10% for full-year.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.